Mersana Therapeutics, Inc.

MRSN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$56,391$76,972$102,287$107,750
Short-Term Investments$0$0$0$26,870
Receivables$168$266$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,429$2,903$3,901$2,284
Total Curr. Assets$59,988$80,141$106,188$136,904
Property Plant & Equip (Net)$2,198$3,932$5,626$6,781
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$657$0
Tax Assets$0$0$0$0
Other NC Assets$500$500$0$978
Total NC Assets$2,698$4,432$6,283$7,759
Other Assets$0$0$0$0
Total Assets$62,686$84,573$112,471$144,663
Liabilities
Payables$2,393$2,923$4,374$4,330
Short-Term Debt$2,293$17,351$12,500$12,500
Tax Payable$0$0$0$0
Deferred Revenue$23,770$20,183$23,715$22,168
Other Curr. Liab.$14,813$427$637$640
Total Curr. Liab.$43,269$59,338$58,161$62,458
LT Debt$0$0$7,901$10,950
Deferred Rev, NC$0$78,381$77,015$79,464
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$78,954$0$0$8
Total NC Liab.$78,954$78,381$85,178$91,714
Other Liabilities$0$0$0$0
Cap. Leases$2,293$3,270$4,223$5,148
Total Liabilities$122,223$137,719$143,339$154,172
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$12$12
Retained Earnings-$951,517-$943,972-$919,676-$895,553
AOCI$0$0$0$10
Other Equity$891,980$0$0$0
Total Equity-$59,537-$53,146-$30,868-$9,509
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$62,686$84,573$112,471$144,663
Net Debt-$54,098-$59,621-$81,886-$84,300